Andrea Benedetti Cacciaguerra

Dr. Andrea Benedetti Cacciaguerra

Hepatobiliary and Abdominal Transplantation Surgery, Department of Experimental and Clinical Medicine, Riuniti Hospital, Polytechnic University of Marche, Ancona, Italy
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 July 2020 in Annals of Surgery
Verified
Journal Article
Closed access
ACAndrea Benedetti Cacciaguerra
Andrea Benedetti Cacciaguerra
BGBurak Görgec
Burak Görgec
FCFederica Cipriani
Federica Cipriani
DADavit Aghayan
Davit Aghayan
GBGiulia Borelli
Giulia Borelli
Mohammed Abu HilalMohammed Abu Hilal
Mohammed Abu Hilal
Objective: To assess the risk factors associated with R1 resection in patients undergoing OLS and LLS for CRLMs. Background: The clinical impact of R1 resection in liver surgery for CRLMs has been continuously appraised, but R1 risk factors have not been clearly defined yet. Methods: A cohort study of patients who underwent OLS and LLS for CRLMs in 9 European high-volume referral centers was performed. A multivariate analysis and the receiver operating characteristic curves were used to investigate the risk factors for R1 resection. A model predicting the likelihood of R1 resection was developed. Results: Overall, 3387 consecutive liver resections for CRLMs were included. OLS was performed in 1792 cases whereas LLS in 1595; the R1 resection rate was 14% and 14.2%, respectively. The risk factors for R1 resection were: the type of resection (nonanatomic and anatomic/nonanatomic), the number of nodules and the size of tumor. In the LLS group only, blood loss was a risk factor, whereas the Pringle maneuver had a protective effect. The predictive size of tumor for R1 resection was >45 mm in OLS and >30 mm in LLS, > 2 lesions was significative in both groups and blood loss >350 cc in LLS. The model was able to predict R1 resection in OLS (area under curve 0.712; 95% confidence interval 0.665–0.739) and in LLS (area under curve 0.724; 95% confidence interval 0.671–0.745). Conclusions: The study describes the risk factors for R1 resection after liver surgery for CRLMs, which may be used to plan better the perioperative strategies to reduce the incidence of R1 resection during OLS and LLS.

6 December 2021 in Journal of Hepato-Biliary-Pancreatic Sciences
Verified
Journal Article
Closed access
PDF file
MMMamoru Morimoto
Mamoru Morimoto
KMKazuteru Monden
Kazuteru Monden
TWTaiga Wakabayashi
Taiga Wakabayashi
NGNaoto Gotohda
Naoto Gotohda
YAYuta Abe
Yuta Abe
GWGo Wakabayashi
Go Wakabayashi

27 September 2017 in Translational Gastroenterology and Hepatology
Verified
Journal Article
Closed access
PDF file
MCMartina Coletta
Martina Coletta
DNDaniele Nicolini
Daniele Nicolini
ACAndrea Benedetti Cacciaguerra
Andrea Benedetti Cacciaguerra
SMSusanna Mazzocato
Susanna Mazzocato
RRRoberta Rossi
Roberta Rossi
MVMarco Vivarelli
Marco Vivarelli
Liver transplant (LT) is considered the best curative treatment for patients with cirrhosis and hepatocellular carcinoma (HCC) within Milan criteria. The possibility to perform LT in HCC patients is limited by the liver grafts supply; indeed, the shortage of donors often leads to a long time on waiting list and then to dropout because of tumor progression. Bridging therapies are neo-adjuvant treatments given to patients on LT waitlist, with the aim to prevent tumor progression and to reduce dropout rate. Many bridging modalities have been proposed. The choice of each treatment is based on the characteristics of the patient, liver function, comorbidities and on the number, dimensions and localization of HCC. This review article describes several types of bridging therapies, focusing on the indications for different kind of patients.

31 May 2025 in British Journal of Surgery
Verified
Journal Article
Open access
Mohammed Abu HilalMohammed Abu Hilal
Mohammed Abu Hilal
THTijs Jan Hoogteijling
Tijs Jan Hoogteijling
BEBjørn Edwin
Bjørn Edwin
IDIbrahim Dagher
Ibrahim Dagher
MDMathieu D'HOndt
Mathieu D'HOndt
HAHoracio J Asbun
Horacio J Asbun

8 March 2022 in Cancers
Verified
Journal Article
Open access
PDF file
Andrew A. GumbsAndrew A. Gumbs
Andrew A. Gumbs
ELEric Lorenz
Eric Lorenz
TTTzu-jung Tsai
Tzu-jung Tsai
LSLee Starker
Lee Starker
JFJoe Flanagan
Joe Flanagan
Mohammed Abu HilalMohammed Abu Hilal
Mohammed Abu Hilal
(1) Background: Here we report on a retrospective study of an international multicentric cohort after minimally invasive liver resection (SIMMILR) of colorectal liver metastases (CRLM) from six centers. (2) Methods: Resections were divided by the approach used: open liver resection (OLR), laparoscopic liver resection (LLR) and robotic liver resection (RLR). Patients with macrovascular invasion, more than three metastases measuring more than 3 cm or a solitary metastasis more than 5 cm were excluded, and any remaining heterogeneity found was further analyzed after propensity score matching (PSM) to decrease any potential bias. (3) Results: Prior to matching, 566 patients underwent OLR, 462 LLR and 36 RLR for CRLM. After PSM, 142 patients were in each group of the OLR vs. LLR group and 22 in the OLR vs. RLR and 21 in the LLR vs. RLR groups. Blood loss, hospital stay, and morbidity rates were all highly statistically significantly increased in the OLR compared to the LLR group, 636 mL vs. 353 mL, 9 vs. 5 days and 25% vs. 6%, respectively (p < 0.001). Only blood loss was significantly decreased when RLR was compared to OLR and LLR, 250 mL vs. 597 mL, and 224 mL vs. 778 mL, p < 0.008 and p < 0.04, respectively. (4) Conclusions: SIMMILR indicates that minimally invasive approaches for CRLM that follow the Milan criteria may have short term advantages. Notably, larger studies with long-term follow-up comparing robotic resections to both OLR and LLR are still needed.

1 July 2020 in Pancreatology
Verified
Journal Article
Closed access
SLSanne Lof
Sanne Lof
ACAndrea Benedetti Cacciaguerra
Andrea Benedetti Cacciaguerra
RARaed Aljarrah
Raed Aljarrah
COChiemezie Okorocha
Chiemezie Okorocha
BJBashar Jaber
Bashar Jaber
Mohammed Abu HilalMohammed Abu Hilal
Mohammed Abu Hilal